Ardelyx Inc (ARDX) concluded trading on Wednesday at a closing price of $3.69, with 7.17 million shares of worth about $26.45 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -34.92% during that period and on June 04, 2025 the price saw a loss of about -6.11%. Currently the company’s common shares owned by public are about 239.20M shares, out of which, 231.09M shares are available for trading.
Stock saw a price change of -5.63% in past 5 days and over the past one month there was a price change of -1.20%. Year-to-date (YTD), ARDX shares are showing a performance of -27.22% which decreased to -46.21% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $3.21 but also hit the highest price of $8.06 during that period. The average intraday trading volume for Ardelyx Inc shares is 5.26 million. The stock is currently trading -2.42% below its 20-day simple moving average (SMA20), while that difference is down -15.56% for SMA50 and it goes to -30.21% lower than SMA200.
Ardelyx Inc (NASDAQ: ARDX) currently have 239.20M outstanding shares and institutions hold larger chunk of about 68.86% of that.
The stock has a current market capitalization of $882.85M and its 3Y-monthly beta is at 0.59. It has posted earnings per share of -$0.23 in the same period. It has Quick Ratio of 3.81 while making debt-to-equity ratio of 1.06. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ARDX, volatility over the week remained 6.71% while standing at 5.10% over the month.
Stock’s fiscal year EPS is expected to drop by -123.94% while it is estimated to increase by 133.86% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Raymond James on May 02, 2025 offering an Outperform rating for the stock and assigned a target price of $11 to it. On March 04, 2025, BTIG Research Initiated their recommendations, while on November 11, 2024, H.C. Wainwright Downgrade their ratings for the stock with a price target of $5.50. Stock get a Neutral rating from Piper Sandler on July 02, 2024.
